Do you want to read an article? Please log in or register.
Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy
Pulmonary Fibrosis
Related content
RECOMMENDED
Pulmonary Fibrosis
Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Barben J, Castellani C, Munck A, Davies JC, deWinter K, Gartner S, Kashirskaya N, Linnane B, Mayell SJ, McColley S, Ooi CY, Proesmans M, Ren CL, Salinas D, Sands D, Sermet-Gaudelus I, Sommerburg O, Southern KW, European CF Society Neonatal Screening Working Group (ECFS NSWG).
doi: 10.1016/j.jcf.2020.11.006
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation
J Pediatr.
Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR
doi: 10.1016/j.jpeds.2016.09.064.
RECOMMENDED
AsthmaPulmonary Fibrosis
New treatments in respiratory medicine in 2018 : asthma, cystic fibrosis and nocturnal positive pressure (CPAP or NIV)
Rev Med Suisse.
Plojoux J, Charbonnier F, Janssens JP
Pulmonary Fibrosis
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis
Radiology.
Dournes G, Berger P, Refait J, Macey J, Bui S, Delhaes L, Montaudon M, Corneloup O, Chateil JF, Marthan R, Fayon M, Laurent F
doi: 10.1148/radiol.2017162350.
The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial
BMC Pulm Med.
Dentice RL, Elkins MR, Dwyer GM, Bye PTP
doi: 10.1186/s12890-017-0568-2.
First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial - preliminary results
Swiss Med Wkly.
Murer C, Huber LC, Kurowski T, Hirt A, Robinson CA, Bürgi U, Benden C
doi: 10.4414/smw.2018.14593.
RECOMMENDED
Pulmonary Fibrosis
Sputum versus nasopharyngeal samples for the molecular diagnosis of respiratory viral infection in cystic fibrosis: A pilot study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Cardot-Martin E, Guillou-Guillemette HL, Berre RL, Ramel S, Bihan JL, Grenet D, Farfour E, Troussier F, Urban T, Billard L, Pilorgé L, Minoui-Tran A, Payan C, Munck MR, Héry-Arnaud G, Vallet S
doi: 10.1016/j.jcf.2020.09.003.
Implementing the International Committee on Mental Health in Cystic Fibrosis (ICMH) guidelines: Screening accuracy and referral-treatment pathways
J Cyst Fibros.
Verkleij M, de Winter D, Hurley MA, Abbott J
doi: 10.1016/j.jcf.
Pulmonary Fibrosis
Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients
Pediatr Pulmonol.
Bruch BA, Singh SB, Ramsey LJ, Starner TD
doi: 10.1002/ppul.24024.